Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedNot Applicable

NCT06408051

Efficacy of 200 IU OnabotulinumtoxinA in Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment

This study aimed to assess the efficacy and safety of onabotulinumtoxinA (botulinum toxin type A) in patients with idiopathic overactive bladder (OAB) and urina…

Turkey (Türkiye)60 participantsStarted 2020-01-01

Treatment: Injection of onabotulinumtoxinA into the bladder wall